Argentina Intranasal Drug And Vaccine Delivery Market Size & Outlook

The intranasal drug and vaccine delivery market in Argentina is expected to reach a projected revenue of US$ 943.5 million by 2030. A compound annual growth rate of 4.8% is expected of Argentina intranasal drug and vaccine delivery market from 2024 to 2030.
Revenue, 2023 (US$M)
$677.4
Forecast, 2030 (US$M)
$943.5
CAGR, 2024 - 2030
4.8%
Report Coverage
Argentina

Argentina intranasal drug and vaccine delivery market, 2018-2030 (US$M)

Argentina

Related Markets

Argentina intranasal drug and vaccine delivery market highlights

  • The Argentina intranasal drug and vaccine delivery market generated a revenue of USD 677.4 million in 2023 and is expected to reach USD 943.5 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
  • In terms of segment, liquid delivery device was the largest revenue generating product in 2023.
  • Powder delivery device is the most lucrative product segment registering the fastest growth during the forecast period.


Intranasal drug and vaccine delivery market data book summary

Market revenue in 2023USD 677.4 million
Market revenue in 2030USD 943.5 million
Growth rate4.8% (CAGR from 2023 to 2030)
Largest segmentLiquid delivery device
Fastest growing segmentPowder delivery device
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPowder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler
Key market players worldwideGSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT


Other key industry trends

  • In terms of revenue, Argentina accounted for 1.0% of the global intranasal drug and vaccine delivery market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil intranasal drug and vaccine delivery market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 1,761.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intranasal Drug And Vaccine Delivery Market Companies

Name Profile # Employees HQ Website

Argentina intranasal drug and vaccine delivery market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.


Liquid delivery device was the largest segment with a revenue share of 43.27% in 2023. Horizon Databook has segmented the Argentina intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.


Healthcare spending in Argentina represents around 7.0% of its total GDP. Around 70.0% to 75.0% of medical products in Argentina are imported. Argentina primarily imports medical devices from the U.S. and is one of the key markets for the U.S. in Latin America.

The U.S. is one of Argentina's noteworthy exporters and is positioned among the best three source nations in the FDI. Furthermore, unavailability or limited availability of resources in Argentina has also restricted many major market players to from entering the market.

Growing preference for cost-effective generics and unfavorable reimbursement scenario may limit the adoption for intranasal drug and vaccine delivery devices. However, the emergence of local players may have a positive impact on the market.

Reasons to subscribe to Argentina intranasal drug and vaccine delivery market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Argentina intranasal drug and vaccine delivery market databook

  • Our clientele includes a mix of intranasal drug and vaccine delivery market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into Argentina intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Argentina intranasal drug and vaccine delivery market size, by product, 2018-2030 (US$M)

Argentina Intranasal Drug And Vaccine Delivery Market Outlook Share, 2023 & 2030 (US$M)

Argentina intranasal drug and vaccine delivery market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more